alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › medication

medication

6 studies tagged medication, dated 2015-06-01 to 2025-07-24. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Systemic medications and dementia risk: a systematic umbrella review 2025-07-24
  2. Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis 2025-02-27
  3. Interactions between antidiabetes medications and heart-brain axis 2024-12-06

Studies

6 studies carry this tag.

Date range

2015 to 2025

Top journals

  • Journal of Alzheimer's disease : JAD 2
  • Current opinion in endocrinology, diabetes, and obesity 1
  • Developmental medicine and child neurology 1
  • Drugs & aging 1
  • Molecular psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Systemic medications and dementia risk: a systematic umbrella review

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Molecular psychiatry 2025-07-24 Drug development

    Currently, there is insufficient evidence to advise repurposing any systemic drugs with the primary aim of reducing dementia risk.

  2. Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 90 out of 100. Journal of Alzheimer's disease : JAD 2025-02-27 Drug development

    42 studies fulfilled inclusion criteria.

  3. Interactions between antidiabetes medications and heart-brain axis

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Current opinion in endocrinology, diabetes, and obesity 2024-12-06 Drug development

    Patients diagnosed with diabetes mellitus have an increased risk of the cardiovascular and neurological diseases.

  4. Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Journal of Alzheimer's disease : JAD 2022-01-01 Drug development

    Insulin and sulfonylurea carried higher mortality risk among dementia patients, while GLP-1a and SGLT-2i were associated with lower risk.

  5. Morbidity and medication in a large population of individuals with Down syndrome compared to the general population

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Developmental medicine and child neurology 2015-08-18 Brain scans and imaging

    The profile of newly occurring morbidities in Down syndrome varies across the developmental lifespan.

  6. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Drugs & aging 2015-06-01 Treatments

    Studies were included for review if they were randomized trials or observational studies on dementia or mild cognitive impairment that evaluated efficacy outcomes or adverse outcomes associated with treatment.

All topic tags with their study counts